Massimo Filippi

Research interests

Publications

• Locus for severity implicates CNS resilience in progression of multiple sclerosis

  Nature · 2023 · https://doi.org/10.1038/s41586-023-06250-x

• 2021 MAGNIMS–CMSC–NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis

  The Lancet Neurology · 2021 · https://doi.org/10.1016/s1474-4422(21)00095-8

• Behavioral and Psychological Effects of Coronavirus Disease-19 Quarantine in Patients With Dementia

  Frontiers in Psychiatry · 2020 · https://doi.org/10.3389/fpsyt.2020.578015

• Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines

  Brain · 2019 · 10.1093/brain/awz144

• Automated classification of Alzheimer's disease and mild cognitive impairment using a single MRI and deep neural networks

  NeuroImage Clinical · 2018 · 10.1016/j.nicl.2018.101645

• Cognition in multiple sclerosis

  Neurology · 2018 · 10.1212/wnl.0000000000004977

• Deep gray matter volume loss drives disability worsening in multiple sclerosis

  Annals of Neurology · 2018 · 10.1002/ana.25145

• Multiple sclerosis

  Nature Reviews Disease Primers · 2018 · https://doi.org/10.1038/s41572-018-0041-4

• Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria

  The Lancet Neurology · 2017 · https://doi.org/10.1016/s1474-4422(17)30470-2

• MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines

  The Lancet Neurology · 2016 · https://doi.org/10.1016/s1474-4422(15)00393-2

• Clinical and imaging assessment of cognitive dysfunction in multiple sclerosis

  The Lancet Neurology · 2015 · 10.1016/s1474-4422(14)70250-9

• Association between pathological and MRI findings in multiple sclerosis

  The Lancet Neurology · 2012 · 10.1016/s1474-4422(12)70003-0

• Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria

  Annals of Neurology · 2011 · https://doi.org/10.1002/ana.22366

• Resting state fMRI in Alzheimer's disease: beyond the default mode network

  Neurobiology of Aging · 2011 · 10.1016/j.neurobiolaging.2011.06.007

• White matter damage in primary progressive aphasias: a diffusion tensor tractography study

  Brain · 2011 · https://doi.org/10.1093/brain/awr099

• Cortical Lesions and Atrophy Associated With Cognitive Impairment in Relapsing-Remitting Multiple Sclerosis

  Archives of Neurology · 2009 · 10.1001/archneurol.2009.174

• Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial

  The Lancet · 2009 · 10.1016/s0140-6736(09)61259-9

• Language networks in semantic dementia

  Brain · 2009 · https://doi.org/10.1093/brain/awp233

• Apolipoprotein E ε4 is associated with disease-specific effects on brain atrophy in Alzheimer's disease and frontotemporal dementia

  Proceedings of the National Academy of Sciences · 2009 · https://doi.org/10.1073/pnas.0812697106

• Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study

  The Lancet · 2008 · https://doi.org/10.1016/s0140-6736(08)60918-6

• Differential diagnosis of suspected multiple sclerosis: a consensus approach

  Multiple Sclerosis Journal · 2008 · 10.1177/1352458508096878

• Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

  Annals of Neurology · 2005 · https://doi.org/10.1002/ana.20703

• Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis

  The Lancet Neurology · 2005 · 10.1016/s1474-4422(05)70071-5

• Evidence of early cortical atrophy in MS

  Neurology · 2003 · 10.1212/01.wnl.0000055926.69643.03

• European/Canadian multicenter, double-blind, randomized, placebo-controlled study of the effects of glatiramer acetate on magnetic resonance imaging--measured disease activity and burden in patients with relapsing multiple sclerosis. European/Canadian Glatiramer Acetate Study Group.

  PubMed · 2001

• Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study

  The Lancet · 2001 · https://doi.org/10.1016/s0140-6736(00)04725-5

• Diffusion tensor magnetic resonance imaging in multiple sclerosis

  Neurology · 2001 · 10.1212/wnl.56.3.304

• European/Canadian multicenter, double‐blind, randomized, placebo‐controlled study of the effects of glatiramer acetate on magnetic resonance imaging–measured disease activity and burden in patients with relapsing multiple sclerosis

  Annals of Neurology · 2001 · 10.1002/ana.64

• Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial

  Nature Medicine · 2000 · 10.1038/80525

• Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis

  The Lancet · 1999 · 10.1016/s0140-6736(98)03053-0

Current projects

No projects listed.